medical-device-investing ChroMedX Reports on HemoPalm Techno-Commercial Analysis and Productization Plan
medical-device-investing ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
medical-device-investing ChroMedX Accelerates Software Development and Implementation Activities; Appoints iGAL Roytblat, Formerly of Kangaroo Group, as CTO, Amid Expansion
medical-device-investing ChroMedX Appoints Raj Kailasanathan as Executive Vice President Corporate Finance
